The Role of UFT in Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|76|5|301-310

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.5, 2009-03, pp. : 301-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II Study of Twenty-Four-Hour Infusion of Irinotecan in Combination with Oral UFT plus Leucovorin for Metastatic Colorectal Cancer

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 338-341

Karger

Access to resources Recommend Favorite

A Phase I Study of UFT-Oral Vinorelbine in Metastatic Breast Cancer

By  

Oncology, Vol. 81, Iss. 2, 2011-09 ,pp. : 73-78

Karger

Access to resources Recommend Favorite

The Role of KRAS Mutations in Predicting the Efficacy of Cetuximab-Plus-Irinotecan Therapy in Irinotecan-Refractory Korean Metastatic Colorectal Cancer Patients

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 224-230

Karger

Access to resources Recommend Favorite

UFT as Maintenance Therapy in Patients with Advanced Colorectal Cancer Responsive to the FOLFOX4 Regimen

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 267-273

Karger

Access to resources Recommend Favorite

Mutational analysis and clinical correlation of metastatic colorectal cancer

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1482-1490

John Wiley & Sons Inc

Access to resources Recommend Favorite